Trump
Health and Human Services Secretary Robert F. Kennedy Jr. speaks as President Donald Trump and Commerce Secretary Howard Lutnick listen during an event on health care affordability in the Oval Office at the White House, Thursday, April 23, 2026, in Washington.
As featured on
President Donald Trump has announced a deal with Regeneron to lower the cost of its pharmaceutical products. The agreement, announced Thursday, includes lowering the prices of current and future drugs on Medicaid and selling a cholesterol drug for $225 on the White House’s discounted drug website, TrumpRx. The deal first reported by NOTUS is part of the Trump administration's efforts to provide economic relief to Americans ahead of the midterm elections. It's one of many deals the White House has struck that aim to align U.S. pharmaceutical prices with other developed nations. Details of these agreements remain undisclosed, but Health Secretary Robert F. Kennedy Jr. says nonproprietary information will be shared with Congress.
Get up-to-the-minute news sent straight to your device.